BridgeMD
New treatment option for ACL Reconstruction
Official title Kinesiophobia vs. Task-Specific Fear: Defining Movement-Related Fear in ACL Reconstruction Patients
ClinicalTrials.gov ID: NCT07190456
What this study is testing
- What it's testing
- Kinesiophobia, defined as an excessive and irrational fear of physical movement due to perceived vulnerability to injury, has gained significant attention in clinical and scientific communities. This condition can act as a barrier to physical activity, negatively impacting patients' disability, quality of life, and the implementation of rehabilitation programs.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 35
You may be able to join if
- The patient must have given their informed consent and signed the consent form.
- The patient must have enough comprehension of the Portuguese language to complete the written questionnaires.
- The patient must have suffered an ACL injury, with or without a history of concomitant meniscal pathology, while playing or training for sport...
- The patient must have undergone anterior cruciate ligament reconstruction surgery.
- The patient must be between 18 and 35 years old.
You likely can't join if
- The subject has a history of repeated ACLR.
- The subject has not injured the ACL while playing sports.
- The subject presents a concurrent psychiatric disorder
- The subject has a history of heart disease and/or peripheral vascular disease and/or metabolic disease and/or Raynaud´s Syndrome.
- The subject is taking any medications known to affect heart rate or blood pressure
- The subject is currently a smoker.
See the full eligibility criteria
- The patient must have given their informed consent and signed the consent form.
- The patient must have enough comprehension of the Portuguese language to complete the written questionnaires.
- The patient must have suffered an ACL injury, with or without a history of concomitant meniscal pathology, while playing or training for sport (recreational or organized).
- The patient must have undergone anterior cruciate ligament reconstruction surgery.
- The patient must be between 18 and 35 years old.
- The patient must still be under medical care/rehabilitation due to the ACL injury.
- The patient must have started jump landing tasks.
- The subject has a history of repeated ACLR.
- The subject has not injured the ACL while playing sports.
- The subject presents a concurrent psychiatric disorder
- The subject has a history of heart disease and/or peripheral vascular disease and/or metabolic disease and/or Raynaud´s Syndrome.
- The subject is taking any medications known to affect heart rate or blood pressure
- The subject is currently a smoker.
The study team makes the final eligibility decision.
Where it's taking place
- Caparica, Almada, Portugal
- Almada, Monte Da Caparica, Portugal
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 35 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Caparica, Almada, Portugal; Almada, Monte Da Caparica, Portugal. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.